COLL logo

COLL

Collegium Pharmaceutical, Inc.NASDAQHealthcare
$32.31-2.83%ClosedMarket Cap: $1.03B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-20HC Wainwright & Co.Buy
2026-03-19NeedhamBuy
2026-01-09HC Wainwright & Co.Buy
2026-01-09BarclaysOverweight
2026-01-08NeedhamBuy
2025-11-07Truist SecuritiesBuy
2025-11-07HC Wainwright & Co.Buy
2025-10-28NeedhamBuy
2025-05-09Piper SandlerNeutral
2025-04-09NeedhamBuy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$7.19$683.0M3
Sun Dec 31$7.10$663.0M1
Mon Dec 31$8.88$741.8M1
Tue Dec 31$9.39$767.9M1